Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
•
Primary Care
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
Related Questions
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
Do you recommend lifelong antibiotic prophylaxis, or do you prefer a more selective approach based on risk factors in asplenic patients without a history of severe infections?
Is immunoglobulin replacement an option for CRS in a patient with normal immune function?
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
Do you give additional pneumococcal vaccines after a dose of PCV20 in patients with asplenia?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
